1. (a) Schedule III consists of each controlled dangerous substance by whatever official name, common or usual name, chemical name, or brand name:

   1. (1) added to Schedule III by the Department under § 5-202(b) of this title; or
   2. (2) designated as a Schedule III controlled dangerous substance by the federal government unless the Department objects under § 5-202(f) of this title.

2. (b) The Department may not add a substance to Schedule III under § 5-202 of this title unless the Department finds:

   1. (1) a potential for abuse of the substance that is less than that for the substances listed in Schedule I and Schedule II;
   2. (2) well documented and approved medical use of the substance in the United States; and
   3. (3) evidence that abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.

Added by Acts 2002, c. 26, § 2, eff. Oct. 1, 2002. Amended by Acts 2018, c. 212, § 1, eff. Oct. 1, 2018; Acts 2019, c. 8, § 1, eff. March 27, 2019; Acts 2020, c. 298, § 1, eff. Oct. 1, 2020; Acts 2022, c. 285, § 1, eff. June 1, 2022; Acts 2022, c. 286, § 1, eff. June 1, 2022.

Formerly Art. 27, §§ 277, 279.